The complement cascade in lung injury and disease.

Similarly, promising data were generated by administration of a C3 inhibitor, namely AMY-101, the administration of which in COVID-19 patients with severe ARDS safely reduced inflammation and ameliorated the syndrome [ 161 , 162 ]; however, the proportion of patients with improved oxygenation did not reach statistical significance in larger trials [ 163 ].

also in 111,027 other papers